Watch RMTG. Know when insiders buy.
One email the day a filing lands. Free.
RMTG
Regenerative Medical Technology Group Inc.
0.06
+0.00 +7.47%
USD · close Sep 25
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
17
FLAG · shorts 17
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $886KP/E —DIV YIELD —FCF YIELD -65.73%REV TTM $9.4M +94.3%NET INCOME −$9.5MNET CASH $1.3M52W 0.02 – 0.12SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $4M | +309.1% | 64.1% | $566K | −$2.9M | — | -0.22 | $332K | $43K | $288K | Aug 19 |
| Q1 2026 · Mar 31 | $2.6M | +93.5% | 66.9% | $230K | −$876K | — | -0.07 | $102K | $315K | −$213K | Jun 9 |
| Q4 2025 · Dec 31derived | $1.6M | +4.0% | 49.6% | −$306K | −$1.4M | — | -0.11 | $38K | $267K | −$229K | May 14 |
| Q3 2025 · Sep 30 | $1.2M | +19.7% | 42.5% | −$446K | −$4.4M | — | -0.35 | −$204K | $225K | −$429K | Nov 19 |
| Q2 2025 · Jun 30 | $983K | +23.9% | 59.6% | −$250K | −$1.4M | — | -0.12 | −$598K | — | — | Aug 19 |
| Q1 2025 · Mar 31 | $1.4M | +67.0% | 69.2% | $135K | −$760K | — | -0.06 | $57K | — | — | Jun 9 |
| Q4 2024 · Dec 31derived | $1.5M | +145.4% | 64.9% | $381K | −$638K | — | -0.05 | $379K | $50K | $329K | May 14 |
| Q3 2024 · Sep 30 | $986K | +52.5% | 75.7% | $20K | −$887K | — | -0.07 | $273K | $54K | $219K | Nov 19 |
| Q2 2024 · Jun 30 | $793K | — | 66.4% | −$214K | −$2.1M | — | -0.17 | $90K | $53K | $38K | Aug 19 |
| Q1 2024 · Mar 31 | $817K | — | 69.6% | −$105K | −$2M | — | -0.16 | $108K | $59K | $49K | May 20 |
| Q4 2023 · Dec 31derived | $616K | — | 70.6% | — | −$256K | — | -0.02 | −$29K | $284K | −$313K | Apr 15 |
| Q3 2023 · Sep 30 | $647K | — | 69.6% | — | −$5.9M | — | -0.47 | $10K | $91K | −$81K | Nov 20 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $5.1M | 55.1% | −$867K | −$7.8M | -153.2% | -0.62 | −$707K | $603K | −$1.3M | — | — |
| FY2024 · to Dec 31 | $4.1M | 68.7% | $81K | −$5.6M | -135.4% | -0.44 | $851K | $215K | $635K | — | — |
| FY2023 · to Dec 31 | $2.4M | 69.5% | −$715K | −$9.8M | -407.2% | -0.79 | −$419K | $386K | −$805K | — | — |
| FY2022 · to Dec 31 | $1.5M | 57.3% | — | −$5.5M | -359.9% | -0.45 | −$1.1M | $198K | −$1.3M | — | — |
| FY2021 · to Dec 31 | $438K | 34.3% | — | −$12.9M | -2942.4% | -1.12 | −$9.9M | — | — | — | — |
| FY2020 · to Dec 31 | $55K | 20.2% | — | −$5.9M | -10703.5% | -0.63 | −$323K | $100K | −$423K | — | — |
Every number comes from Regenerative Medical Technology Group Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.